Literature DB >> 3501362

Early loss of blue-sensitive color vision in patients with type I diabetes.

M L Daley1, R C Watzke, M C Riddle.   

Abstract

Existing methods for early detection of ocular injury from diabetes have serious limitations. We describe a new method, measuring visual flicker discrimination of the blue-sensitive mechanism of vision. This method is noninvasive, quantitative, and capable of distinguishing two types of impairment. Blue-flicker discrimination was measured in 10 adults with type I (insulin-dependent) diabetes for less than 5 yr. Although no evidence of diabetic changes was detected by careful ophthalmic examination by an experienced ophthalmologist, 12 of 19 eyes (63%) had flicker discrimination scores considered abnormal in comparison with those of a control group, and 8 of 10 subjects (80%) had at least 1 eye with abnormal performance. In all but 2 abnormal eyes the deficit of blue-flicker discrimination was of the "absorptive" type, suggesting increased absorbance or scattering of blue light in the optical media. These data show that a functional impairment of vision can be measured very early in the course of type I diabetes, before visible retinopathy is present, and suggest this test procedure may have both investigative and clinical applications.

Entities:  

Mesh:

Year:  1987        PMID: 3501362     DOI: 10.2337/diacare.10.6.777

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  21 in total

Review 1.  A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Authors:  Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez
Journal:  Prog Retin Eye Res       Date:  2006-09-01       Impact factor: 21.198

2.  Diabetic Retinopathy and the NMDA Receptor.

Authors:  Sylvia B. Smith
Journal:  Drug News Perspect       Date:  2002-05

3.  Blue flash ERG PhNR changes associated with poor long-term glycemic control in adolescents with type 1 diabetes.

Authors:  Michelle McFarlane; Tom Wright; Derek Stephens; Josefin Nilsson; Carol A Westall
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

Review 4.  An integrated approach to diabetic retinopathy research.

Authors:  Thomas W Gardner; Steven F Abcouwer; Alistair J Barber; Gregory R Jackson
Journal:  Arch Ophthalmol       Date:  2011-02

5.  Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.

Authors:  Jan J Blom; Thomas J Giove; Tara L Favazza; James D Akula; William D Eldred
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-12

6.  Screening of diabetics who read incorrectly colour-dependent glucose test-strips.

Authors:  M Mäntyjärvi
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

7.  Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.

Authors:  S-H Park; J-W Park; S-J Park; K-Y Kim; J-W Chung; M-H Chun; S-J Oh
Journal:  Diabetologia       Date:  2003-07-31       Impact factor: 10.122

8.  Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.

Authors:  Mohamed Al-Shabrawey; Sylvia Smith
Journal:  EPMA J       Date:  2010-03-23       Impact factor: 6.543

9.  Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy.

Authors:  Thomas J Giove; Monika M Deshpande; Christine S Gagen; William D Eldred
Journal:  Mol Vis       Date:  2009-11-09       Impact factor: 2.367

10.  Diabetes changes the levels of ionotropic glutamate receptors in the rat retina.

Authors:  Ana R Santiago; Joana M Gaspar; Filipa I Baptista; Armando J Cristóvão; Paulo F Santos; Willem Kamphuis; António F Ambrósio
Journal:  Mol Vis       Date:  2009-08-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.